Cue Health to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01 2022 - 4:01PM
Business Wire
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, announced today that its management team will present at
the BTIG MedTech, Digital Health, Life Science & Diagnostic
Tools Conference on Tuesday, February 15, 2022 at 12:30 p.m.
Eastern Time.
The webcast link is available only for those who are attending
the BTIG conference.
About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company
that makes it easy for individuals to access health information and
places diagnostic information at the center of care. Cue Health
enables people to manage their health through real-time,
actionable, and connected health information, offering individuals
and their healthcare providers easy access to lab-quality
diagnostics anywhere, anytime, in a device that fits in the palm of
the hand. Cue Health's first-of-its-kind COVID-19 test was the
first FDA-authorized molecular diagnostic test for at-home and
over-the-counter use without a prescription and physician
supervision. Outside the United States, Cue Health has received the
CE mark in the European Union, Interim Order authorization from
Health Canada, regulatory approval from India's Central Drugs
Standard Control Organization, and PSAR authorization from
Singapore’s Health Sciences Authority. Cue was founded in 2010 and
is headquartered in San Diego. For more information, please visit
www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220201006062/en/
ICR Westwicke Caroline Corner ir@cuehealth.com (415)
202-5678
Cue Health press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From May 2024 to Jun 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2023 to Jun 2024